We serve dipotassium tetrachloroplatinate CAS:10025-99-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Uses: Used as a raw material for preparing divalent or zero-valent platinum complexes.
| Test items | Standard | Test results |
| Aspect | Red-pink crystalline powder | Complies |
| Solubility | Freely soluble in water | Complies |
| Identification | Identification of potassium salt in this product |
Positive response |
| Potassium hexachloroplatinate(Ⅳ) |
≤0.1% | 0.003% |
| Loss on drying | <0.5% | 0.07% |
| Platinum content | 46.3~47.0% | 46.6% |
| href="javaｓｃｒｉｐｔ:void(0);" Conclusion | The product is up to standard | |
Contact us for information like dipotassium tetrachloroplatinate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Potassium chloroplatinite physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Potassium chloroplatinite Use and application,Potassium chloroplatinite technical grade,usp/ep/jp grade.
Related News: Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries.(R)-2-((4aR,6R,7R,8R,8aS)-7-Acetylamino-6-cyclohexyloxy-2-phenyl-hexahydro-pyrano[3,2-d][1,3]dioxin-8-yloxy)-propionic acid manufacturer When a new strain emerges that has not yet been identified, as is the case with the current outbreak in China, it temporarily becomes known as a novel coronavirus (nCoV).cyclobutane-1,1-dicarboxylic acid supplier The victim — who died Saturday — was a 44-year-Chinese man who flew in from Wuhan in January.2,6-Dinitro-1,3,5-tris-octylamino-benzol vendor The victim — who died Saturday — was a 44-year-Chinese man who flew in from Wuhan in January.The drug, Imfinzi, when added to chemotherapy and the drugmaker’s other cancer drug tremelimumab, significantly improved the survival of patients without the disease progressing, when compared to chemotherapy alone, the company said.
